Aarden Pharmaceuticals, Inc. — Form D/A
Aarden Pharmaceuticals, Inc. of INDIANAPOLIS, IN, a company, filed a Form D amendment with the SEC on 2011-01-03. The offering totals $500K, of which $500K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2011-01-03
- Form: D/A
- Accession: 0001507273-11-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $500K
- Amount sold: $500K
- Minimum investment: $250K
- Investors: 2
- Date of first sale: 2010-11-23
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-151550
Issuer
- Name: Aarden Pharmaceuticals, Inc.
- CIK: 0001507273
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2008
- Address: 351 W. 10TH STREET, SUITE 248, INDIANAPOLIS, IN, 46202
- Phone: 317-690-2453
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Thomas M Estok | Director | Carlsbad, CA |
| Christopher C LeMasters | Director | San Diego, CA |
| Gary M Noonan | Director | Indianapolis, IN |
| Zhong Yin Zhang | Director | Indianapolis, IN |
| Francis J Burrows | Executive Officer | San Diego, CA |
| Gary M Noonan | Executive Officer | Indianapolis, IN |
Other filings by this issuer (1)
More